MedTrace Logo

Diagnosis of Superficial Lymphadenopathy

NCT04928560 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-06-16

No results posted yet for this study

Summary

The purpose of this study is to study the application of CEUS and SMI technology in superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Conditions

  • Lymphadenopathy
  • ULTRASOUND

Interventions

DIAGNOSTIC_TEST

SMI

ULTRASOUND

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • pintong Huang · Second Affiliated Hospital, School of Medicine, Zhejiang University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2020-12-30
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04928560 on ClinicalTrials.gov